Cargando…

Erratum: Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Erratum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10688276/ https://www.ncbi.nlm.nih.gov/pubmed/38045504 http://dx.doi.org/10.4103/0974-1208.386502

Ejemplares similares

Clinical Outcomes in Patients Receiving Originator Follitropin Alfa and Follitropin Alfa Biosimilars in Real-world Clinical Practice: A Retrospective Study
por: Patel, Nayana Hitesh, et al.
Publicado: (2023)

Glycosylation Pattern and in vitro Bioactivity of Reference Follitropin alfa and Biosimilars
por: Riccetti, Laura, et al.
Publicado: (2019)

Comparative Assessment of the Structural Features of Originator Recombinant Human Follitropin Alfa Versus Recombinant Human Follitropin Alfa Biosimilar Preparations Approved in Non-European Regions
por: Manzi, Lucio, et al.
Publicado: (2022)

Recombinant follitropin alfa/lutropin alfa in fertility treatment
por: Gibreel, Ahmed, et al.
Publicado: (2010)

A cost-effectiveness evaluation comparing originator follitropin alfa to the biosimilar for the treatment of infertility
por: Gizzo, Salvatore, et al.
Publicado: (2016)

Safety of Follitropin Alfa/Lutropin Alfa for Stimulation of Follicular Development
por: Abramova, Nadezda, et al.
Publicado: (2018)

In vitro fertilization cycles stimulated with follitropin delta result in similar embryo development and quality when compared with cycles stimulated with follitropin alfa or follitropin beta
por: Haakman, Olga, et al.
Publicado: (2020)

Clinical Efficacy of Follitropin Alfa in GnRH-Antagonist Protocols: A Prospective Observational Phase IV Study on the Use of Biosimilar Follitropin Alfa r-hFSH in Assisted Reproductive Technology in a Routine Care Setting
por: Griesinger, Georg, et al.
Publicado: (2021)

Administration of follitropin alfa and lutropin alfa combined in a single injection: a feasibility assessment
por: Agostinetto, Rita
Publicado: (2009)

A 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice: a large, multicentre, observational study
por: Bühler, Klaus, et al.
Publicado: (2011)

Managing infertility with the follitropin alfa prefilled pen injector – patient considerations
por: Bühler, Klaus
Publicado: (2015)

Comparing a biosimilar follitropin alfa (Cinnal-fⓇ) with Gonal-fⓇ in women undergoing ovarian stimulation: An RCT
por: Hossein Rashidi, Batool, et al.
Publicado: (2021)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders
por: Humaidan, P., et al.
Publicado: (2017)

Ovulation induction with minimal dose of follitropin alfa: a case series study
por: Bruna-Catalán, Isidoro, et al.
Publicado: (2011)

The Effect of Follitropin Alfa in Controlled Ovarian Stimulation Protocol for In Vitro Fertilization Cycles
por: Prasetiawati, Novita, et al.
Publicado: (2023)

Assessment of the biopotency of follitropin alfa and lutropin alfa combined in one injection: a comparative trial in Sprague-Dawley rats
por: Alper, Michael, et al.
Publicado: (2008)

Human factors engineering and design validation for the redesigned follitropin alfa pen injection device
por: Mahony, Mary C, et al.
Publicado: (2015)

A redesigned follitropin alfa pen injector for infertility: results of a market research study
por: Abbotts, Carole, et al.
Publicado: (2011)

A comparison of menotropin, highly-purified menotropin and follitropin alfa in cycles of intracytoplasmic sperm injection
por: Esteves, Sandro C, et al.
Publicado: (2009)

A large, multicentre, observational, post-marketing surveillance study of the 2:1 formulation of follitropin alfa and lutropin alfa in routine clinical practice for assisted reproductive technology
por: Bühler, Klaus, et al.
Publicado: (2014)

A Novel Follitropin Analog Inhibits Follitropin Activity In Vitro
por: Azzam, Naiel, et al.
Publicado: (2021)

The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review
por: Velthuis, Erica, et al.
Publicado: (2020)

A cost-effectiveness evaluation of the originator follitropin alpha compared to the biosimilars for assisted reproduction in Germany
por: Xue, Weiguang, et al.
Publicado: (2019)

Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
por: Chua, Su Jen, et al.
Publicado: (2021)

Patient evaluation of the use of follitropin alfa in a prefilled ready-to-use injection pen in assisted reproductive technology: an observational study
por: Welcker, J Thomas, et al.
Publicado: (2010)

Corifollitropin alfa versus follitropin beta: an economic analysis alongside a randomized controlled trial in women undergoing IVF/ICSI
por: Khoa, Le Dang, et al.
Publicado: (2020)

Correction to: The Frequency of Ovarian Hyperstimulation Syndrome and Thromboembolism with Originator Recombinant Human Follitropin Alfa (GONAL-f) for Medically Assisted Reproduction: A Systematic Review
por: Velthuis, Erica, et al.
Publicado: (2021)

Correction: Biosimilar recombinant follitropin alfa preparations versus the reference product (Gonal-F®) in couples undergoing assisted reproductive technology treatment: a systematic review and meta-analysis
por: Venetis, Christos A., et al.
Publicado: (2023)

Safety of Ovaleap® (Follitropin Alfa) in Infertile Women Undergoing Superovulation for Assisted Reproductive Technologies: A Multinational Comparative, Prospective Cohort Study
por: Kaplan, Sigal, et al.
Publicado: (2021)

Effectiveness and safety of follitropin alfa (Ovaleap®) for ovarian stimulation using a GnRH antagonist protocol in real-world clinical practice: a multicenter, prospective, open, non-interventional assisted reproductive technology study
por: Sydow, Peter, et al.
Publicado: (2020)

Comparison of follitropin β administered by a pen device with follitropin β administered by a conventional syringe in patients undergoing IVF-ET
por: Kang, Hyuk-Jae, et al.
Publicado: (2011)

Single-arm, observational study of the ease of use of a redesigned pen device to deliver recombinant human follicle-stimulating hormone (follitropin alfa) for assisted reproductive technology treatment
por: Illingworth, Peter J, et al.
Publicado: (2014)

Multicenter, noninterventional, post-marketing surveillance study to evaluate dosing of recombinant human follicle-stimulating hormone using the redesigned follitropin alfa pen in women undergoing ovulation induction
por: Nawroth, Frank, et al.
Publicado: (2015)

Prospective multicenter non-interventional real-world study to assess the patterns of use, effectiveness and safety of follitropin delta in routine clinical practice (the PROFILE study)
por: Blockeel, Christophe, et al.
Publicado: (2022)

Erratum to: Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years’ treatment
por: Kampmann, Christoph, et al.
Publicado: (2016)

Phase III trial comparing the efficacy and safety of recombinant‐ or urine‐derived human chorionic gonadotropin for ovulation triggering in Japanese women diagnosed with anovulation or oligo‐ovulation and undergoing ovulation induction with follitropin‐alfa
por: Ikenaga, Hideyuki, et al.
Publicado: (2016)

In Vitro Effects of the Endocrine Disruptor p,p’-DDT on Human Follitropin Receptor
por: Munier, Mathilde, et al.
Publicado: (2016)

Pharmacokinetics and Safety of Follitropin Delta in Gonadotropin Down-Regulated Healthy Chinese Women
por: Shao, Feng, et al.
Publicado: (2022)

A Narrative Review Discussing the Efficiency of Personalized Dosing Algorithm of Follitropin Delta for Ovarian Stimulation and the Reproductive and Clinical Outcomes
por: Doroftei, Bogdan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8cr1i0rnc8epvk995tne2jnmsl